MediciNova Inc.

01/30/2023 | Press release | Distributed by Public on 01/30/2023 17:02

MediciNova Announces Completion of Enrollment in the Phase 2b Clinical Trial of MN 166 (ibudilast) in Alcohol Use Disorder